Scott Kokones is co-founder and CEO of Enspire DBS Therapy, a Cleveland Clinic portfolio company building an implantable deep brain stimulation system paired with physical rehab to restore arm function in stroke survivors. He is running the RESTORE pivotal trial after the EDEN proof-of-concept study, having raised $27.9M total including a $17.6M Series B in 2023 and a $10.3M Series B1 in January 2026. Alongside Enspire he is a general partner at Guide Medical Ventures and a co-founder of Qr8 Health and CardioSolv Ablation Technologies. His earlier career runs through Intelect Medical, Boston Scientific, Enpath Medical, and Medtronic.
Scientific Learning, now part of Carnegie Learning, builds neuroscience-based reading and language software that rewires how struggling readers process language. Its flagship Fast ForWord program treats reading difficulty at its root - the brain's ability to process sound and sequence information - rather than drilling worksheets. Born from lab research by four scientists in 1996 and acquired by Carnegie Learning in 2020, the company has delivered cognitive-skills and reading interventions to students in more than 40 countries, backed by decades of peer-reviewed research.